Sign In
Last checked at 
10 Jul 2012 08:09
10 July 2012
Revolymer plc
("Revolymer" or "the Group")
Julian Heslop to Join the Board of Revolymer
Former CFO of GSK to become an Independent Non-Executive Director
Revolymer, the British polymer company developing products for a number of high value fast moving consumer goods ("FMCG") markets, is pleased to announce that, as a consequence of the Group's admission to the AIM Market today, the appointment of Julian Heslop to the Board has now become effective.
Julian served as Chief Financial Officer of GlaxoSmithKline plc ("GSK") between April 2005 and March 2011. He was also Chairman of ViiV Healthcare Limited until March 2011. He served as Senior Vice President, Operations Controller of GSK between January 2001 and March 2005 and as Financial Controller of Glaxo Wellcome plc from April 1998 to December 2000. Prior to this, Julian had senior finance roles at Grand Metropolitan plc and Imperial Brewing and Leisure. He is a Fellow of the Institute of Chartered Accountants in England and Wales.
Julian Heslop, commenting on his appointment said, "I am delighted to be joining the Board of Revolymer. I look forward to playing an active role as the Group seeks to generate significant value from its broad product pipeline by signing a number of licensing deals with important players in the FMCG markets it is targeting."
Jack Keenan, Chairman of Revolymer commenting on today's announcement said, "Julian's decision to join the Board of Revolymer, upon its Admission to AIM, is an important endorsement of the Group's technology and the market opportunities that it has chosen to pursue. His financial knowledge and experience in both pharmaceutical and FMCG markets will be extremely valuable as the company seeks to develop its business."
Further information on Julian Spenser Heslop as required by AIM Rule 17 and Schedule Two, paragraph (g) of the AIM Rules for Companies is to be found in paragraph 4 of Part VI of the Group's Admission Document which was published on 4 July 2012 and available at www.revolymer.com
Ends
Revolymer plc | +44 (0) 1244 283 500 |
Roger Pettman Rob Cridland |
|
Panmure Gordon (UK) Limited | +44 (0) 20 7459 3600 |
Callum Stewart / Adam James (Corporate Finance) Adam Pollock / Charles Leigh-Pemberton (Corporate Broking) |
|
Citigate Dewe Rogerson | +44 (0)20 7638 9571 |
Ginny Pulbrook / David Dible |
|
About Revolymer
Revolymer® is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. Current applications for the Group's technologies are in the confectionery chewing gum and medicated chewing gum (together "gum") markets; and in coatings & adhesives, household products and personal care (together "consumer specialties").
www.revolymer.com
Follow the stocks
